Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof

1. A compound of formula (I):

wherein:

R 1 represents:

a phenyl group or a naphthyl group, wherein these two groups are optionally substituted by one or more atoms or groups chosen, independently of one another, from the following atoms or groups: halogen, (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, (C 1 -C 10 )thioalkyl, —S(O)(C 1 -C 10 )alkyl, —S(O) 2 (C 1 -C 10 )alkyl, hydroxyl, cyano, nitro, hydroxy(C 1 -C 10 )alkylene, NRaRb(C 1 -C 10 )alkylene, (C 1 -C 10 )alkoxy(C 1 -C 10 )alkyleneoxy, NRaRb, CONRaRb, SO 2 NRaRb, NRcCORd, OC(O)NRaRb, OCO(C 1 -C 10 )alkyl, NRcC(O)ORe, NRcSO 2 Re, aryl(C 1 -C 10 )alkylene, monocyclic aryl or monocyclic heteroaryl, wherein the monocyclic aryl or monocyclic heteroaryl are optionally substituted by one or more substituents chosen from a halogen and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, oxo, nitro, cyano or OCO(C 1 -C 10 )alkyl group;

X represents from 1 to 4 substituents which are identical to or different from one another and which are chosen from halogen, (C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, NRaRb, cyano and nitro, wherein the (C 1 -C 10 )alkyl is optionally substituted by one or more groups chosen from a halogen, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb and hydroxyl;

R 2 and R 3 represent, independently of one another,

a hydrogen atom,

a (C 1 -C 10 )alkyl group, this group being optionally substituted by an Rf group; or an aryl group, optionally substituted by one or more substituents chosen from a halogen and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro or cyano group;

R 2 and X can together form, with the carbon atoms which carry them, a carbon ring of 5 to 7 carbon atoms;

R 4 represents:

a hydrogen atom,

a (C 1 -C 10 )alkyl group, this group being optionally substituted by an Rf group; or an aryl group, optionally substituted by one or more substituents chosen from a halogen and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro, cyano, (C 1 -C 10 )alkyl(CO)—, CONRaRb, NRcCORd, OC(O)NRaRb, OCO(C 1 -C 10 )alkyl, NRcC(O)ORe or aryl group, wherein the aryl is optionally substituted by one or more substituents chosen from a halogen and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro or cyano group;

Ra and Rb represent, independently of one another,

a hydrogen atom or a (C 1 -C 10 )alkyl, aryl(C 1 -C 10 )alkylene or aryl group;

or Ra and Rb together form, with the nitrogen atom which carries them, an azetidine, pyrrolidine, piperidine, azepine, morpholine, thiomorpholine, piperazine or homopiperazine group, this group being optionally substituted by a (C 1 -C 10 )alkyl, aryl or aryl(C 1 -C 10 )alkylene group;

Rc and Rd represent, independently of one another,

a hydrogen atom or a (C 1 -C 10 )alkyl, aryl(C 1 -C 10 )alkylene or aryl group;

or Rc and Rd together form a (C 2 -C 5 )alkylene group;

Re represents

a (C 1 -C 10 )alkyl, aryl(C 1 -C 10 )alkylene or aryl group;

or Rc and Re together form a (C 2 -C 5 )alkylene group; and

Rf represents

a halogen atom or a (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, hydroxyl, cyano, NRaRb, C(O)NRaRb, NRcCORd, OC(O)NRaRb, OCO(C 1 -C 10 )alkyl, NRcCOORe, SO 2 NRaRb, NRcSO 2 Re, aryl(C 1 -C 10 )alkylene or aryl group, wherein the aryl is optionally substituted by one or more substituents chosen from a halogen or a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro, cyano or OCO(C 1 -C 10 )alkyl group;

or an acid addition salt thereof.

2. The compound of formula (I) according to claim 1 , wherein:

R 1 represents a phenyl group or a naphthyl group optionally substituted by one or more atoms or groups chosen, independently of one another, from halogen atoms and (C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, nitro, —S(O) 2 (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, cyano, (C 1 -C 10 )thioalkyl, NRaRb, NRcCORd, hydroxy(C 1 -C 10 )alkylene, NRcSO 2 Re, CONRaRb, NRcC(O)ORe, SO 2 NRaRb or NRaRb(C 1 -C 10 )alkylene groups;

Ra and Rb represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

or Ra and Rb together form, with the nitrogen atom which carries them, a pyrrolidinyl or morpholinyl group;

Rc and Rd represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group; and

Re represents a (C 1 -C 10 )alkyl group;

or an acid addition salt thereof.

3. The compound of formula (I) according to claim 1 , wherein:

X represents 1 or 2 substituents, identical to or different from one another, chosen from halogen, (C 1 -C 10 )alkyl or (C 1 -C 10 )alkoxy, it being possible for (C 1 -C 10 )alkyl to be optionally substituted by a hydroxyl group;

R 2 and X can together form, with the carbon atoms which carry them, a carbon ring of 5 or 6 carbons;

or an acid addition salt thereof.

4. The compound of formula (I) according claim 1 , wherein:

R 2 and R 3 represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

or an acid addition salt thereof.

5. The compound of formula (I) according to claim 1 , wherein:

R 4 represents a hydrogen atom or a (C 1 -C 10 )alkyl group, this group optionally being substituted by an Rf group; and

Rf represents a (C 1 -C 10 )alkoxy group;

or an acid addition salt thereof.

6. The compound of formula (I) according to claim 1 , wherein:

the substitution of the

group on the phenyl ring is in the 2, 3 or 4 position; or an acid addition salt thereof.

7. The compound of formula (I) according to claim 1 , wherein:

R 1 represents a phenyl group or a naphthyl group, optionally substituted by one or more atoms or groups chosen, independently of one another, from halogen atoms and (C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, nitro, —S(O) 2 (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, cyano, (C 1 -C 10 )thioalkyl, NRaRb, NRcCORd, hydroxy(C 1 -C 10 )alkylene, NRcSO 2 Re, CONRaRb, NRcC(O)ORe, SO 2 NRaRb or NRaRb(C 1 -C 10 )alkylene groups;

Ra and Rb represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

or Ra and Rb together form, with the nitrogen atom which carries them, a pyrrolidinyl or morpholinyl group;

Rc and Rd represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

Re represents a (C 1 -C 10 )alkyl group;

X represents 1 or 2 substituents, identical to or different from one another, chosen from halogen, (C 1 -C 10 )alkyl, and (C 1 -C 10 )alkoxy, wherein the (C 1 -C 10 )alkyl group is optionally substituted by a hydroxyl group;

R 2 and X can together form, with the carbon atoms which carry them, a carbon ring of 5 or 6 carbons;

R 2 and R 3 represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

R 4 represents a hydrogen atom or a (C 1 -C 10 )alkyl group, this group being optionally substituted by an Rf group;

Rf represents a (C 1 -C 10 )alkoxy group; and

the substitution of the

group on the phenyl ring is in the 2, 3 or 4 position;

or an acid addition salt thereof.

8. The compound of formula (I) according to claim 1 , wherein:

R 1 represents a phenyl group optionally substituted by a halogen or a (C 1 -C 10 )alkyl or (C 1 -C 10 )alkoxy group;

X represents one or more halogen, (C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy or hydroxy(C 1 -C 10 )alkyl;

R 2 and R 3 represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

R 2 and X can together form, with the carbon atoms which carry them, a carbon ring of 6 carbon atoms; and

R 4 represents a hydrogen atom,

or an acid addition salt thereof.

9. A compound selected from the group consisting of:

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-fluorophenyl}methanol;

1-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-fluorophenyl}ethanol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2,6-difluorophenyl}methanol;

1-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2,6-difluorophenyl}ethanol;

1-{5-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-fluorophenyl}ethanol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-5-methylphenyl}methanol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-5-methoxyphenyl}methanol;

7-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-1,2,3,4-tetrahydronaphth-1-ol;

5-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-1,2,3,4-tetrahydronaphth-1-ol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-4-methylphenyl}methanol;

{5-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-fluorophenyl}methanol;

{5-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-methylphenyl}methanol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-methylphenyl}methanol;

[2-Fluoro-4-(2-(p-tolyl)imidazo[1,2-a]pyridin-6-yl)phenyl]methanol;

[2-Fluoro-6-(2-(p-tolyl)imidazo[1,2-a]pyridin-6-yl)phenyl]methanol;

{2-Fluoro-6-[2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2-Fluoro-4-[2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol and its hydrochloride;

[2-Fluoro-4-(2-phenylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol and its hydrochloride;

{2-Fluoro-3-[2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

[2-Fluoro-6-(2-phenylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol and its hydrochloride;

[2-Fluoro-3-(2-(p-tolyl)imidazo[1,2-a]pyridin-6-yl)phenyl]methanol;

1-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-4-fluorophenyl}ethanol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-4-fluorophenyl}methanol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-4-methoxyphenyl}methanol;

1-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-4-methoxyphenyl}ethanol;

{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-5-(hydroxymethyl)phenyl}methanol;

[2-Fluoro-3-[2-(naphth-2-yl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanol;

[2-Fluoro-3-(2-phenylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol and its hydrochloride;

(+)-1-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-4-fluorophenyl}ethanol;

(−)-1-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-4-fluorophenyl}ethanol;

{2-[2-(2,4-Difluorophenyl)imidazo[1,2-a]pyridin-6-yl]-6-fluorophenyl}methanol;

{3-[2-(2,4-Difluorophenyl)imidazo[1,2-a]pyridin-6-yl]-2,6-difluorophenyl}methanol;

2-{4-Fluoro-3-[2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}propan-2-ol;

1-{4-Fluoro-3-[2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}ethanol;

2-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2,6-difluorophenyl}propan-2-ol;

1-[4-Fluoro-2-(2-(naphth-2-yl)imidazo[1,2-a]pyridin-6-yl)phenyl]ethanol;

6-(2,4-Difluoro-3-methoxymethylphenyl)-2-(p-tolyl)imidazo[1,2-a]pyridine;

{2-Fluoro-6-[2-(4-nitrophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2,6-Difluoro-3-[2-(4-(pyrrolidin-1-yl)phenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{3-[2-(3,4-Difluorophenyl)imidazo[1,2-a]pyridin-6-yl]-2,6-difluorophenyl}methanol;

{2,6-Difluoro-3-[2-(2-fluorophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{3-[2-(3-Bromophenyl)imidazo[1,2-a]pyridin-6-yl]-2,6-difluorophenyl}methanol;

{2,6-Difluoro-3-[2-(4-methylsulphonylphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

2-[2-Methyl-3-(2-phenylimidazo[1,2-a]pyridin-6-yl)phenyl]propan-2-ol;

7-[2-(2,4-Difluorophenyl)imidazo[1,2-a]pyridin-6-yl]indan-1-ol;

2-(4-Chlorophenyl)-6-[2,4-difluoro-3-[(2-methoxyethyl)oxymethyl]phenyl]imidazo[1,2-a]pyridine;

7-[2-(2,4-Difluorophenyl)imidazo[1,2-a]pyridin-6-yl]-1-methylindan-1-ol;

2-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-methoxyphenyl}propan-2-ol;

1-{3-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-2-methoxyphenyl}ethanol;

{2-Fluoro-6-[2-(4-trifluoromethylphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2-Fluoro-6-[2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2-Fluoro-6-[2-(4-(pyrrolidin-1-yl)phenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2-Fluoro-6-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2-[2-(3,4-Difluorophenyl)imidazo[1,2-a]pyridin-6-yl]-6-fluorophenyl}methanol;

3-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]benzonitrile;

{2-Fluoro-6-[2-(2-fluorophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2-[2-(3-Bromophenyl)imidazo[1,2-a]pyridin-6-yl]-6-fluorophenyl}methanol;

{2-[2-(4-Chloro-3-methylphenyl)imidazo[1,2-a]pyridin-6-yl]-6-fluorophenyl}methanol;

{2-[2-(3-Chloro-4-methylphenyl)imidazo[1,2-a]pyridin-6-yl]-6-fluorophenyl}methanol;

{2-Fluoro-6-[2-(4-methylsulphonylphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2,6-Difluoro-3-[2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2,6-Difluoro-3-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

3-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]benzonitrile;

{2,6-Difluoro-3-[2-(4-chloro-3-methylphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2,6-Difluoro-3-[2-(3-chloro-4-methylphenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{2,6-Difluoro-3-[2-(4-methylthiophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

2-[2-Chloro-3-[2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl]propan-2-ol;

1-[2-Chloro-3-[2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]phenyl]ethanol;

{2-[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-6-yl]-6-fluorophenyl}methanol;

2-(4-Chlorophenyl)-6-[3-fluoro-2-[(2-methoxyethyl)oxymethyl]phenyl]imidazo[1,2-a]pyridine;

N-{3-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}acetamide;

{4-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}methanol

{3-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}methanol;

N-{4-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}methanesulphonamide;

4-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-N,N-dimethylbenzamide;

Methyl {4-[6-(3-fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}carbamate;

4-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-N-methylbenzamide;

N-{4-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}acetamide;

{2-Fluoro-6-[2-(4-(morpholin-4-yl)phenyl)imidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

3-[6-(3-Fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-N,N-dimethylbenzenesulphonamide;

(2-Fluoro-6-{2-[4-(1-(pyrrolidin-1-yl)ethyl)phenyl]imidazo[1,2-a]pyridin-6-yl}phenyl)methanol;

2-Fluoro-4-[6-(3-fluoro-2-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-N,N-dimethylbenzamide;

N-{3-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}acetamide;

{4-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}methanol;

{3-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}methanol;

4-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-N,N-dimethylbenzamide;

Methyl {4-[6-(2,4-difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}carbamate;

4-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-N-methylbenzamide;

N-{4-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}acetamide;

{2,6-Difluoro-3-[2-(4-(morpholin-4-yl)phenyl)imidazo[1,2-a]pyridin-6-yl]-phenyl}methanol;

N-{3-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]phenyl}isobutyramide;

3-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-N,N-dimethylbenzenesulphonamide;

(2,6-Difluoro-3-{2-[4-(1-(pyrrolidin-1-yl)ethyl)phenyl]imidazo[1,2-a]pyridin-6-yl}phenyl)methanol; and

4-[6-(2,4-Difluoro-3-hydroxymethylphenyl)imidazo[1,2-a]pyridin-2-yl]-2-fluoro-N,N-dimethylbenzamide;

or an acid addition salt thereof.

10. A pharmaceutical composition comprising a compound of formula (I) according to claim 1 or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

11. A pharmaceutical composition comprising a compound of formula (I) according to claim 9 or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

12. A process for the synthesis of the compound of formula (I) according to claim 1 , comprising reacting a compound of formula (II)

wherein R1 is as defined in claim 1 and Y represents a halogen atom or a boron derivative, with a derivative of formula (III), wherein X is defined according to claim 1 and Z represents a boron or tin derivative if Y represents a halogen atom, or else Z represents a halogen atom, if Y represents a boron derivative, and R5 represents the

group.

13. A process for the synthesis of the compound of formula (I) according to claim 1 , comprising reacting a compound of formula (VI):

wherein R2, R3 and X are defined according to claim 1 and R7 represents R4 as defined in claim 1 or a protective group for the hydroxyl functional group PG, with a bromoketone of formula (VII):

wherein R1 is defined according to claim 1 .

14. A process for the synthesis of the compound of formula (I) according to claim 1 , comprising reacting a compound of formula (II):

wherein R1 is defined according to claim 1 and Y represents a halogen atom or a boron derivative, with a derivative of formula (III):

wherein X is defined according to claim 1 and Z represents a boron or tin derivative when Y represents a halogen atom, or Z represents a halogen atom when Y represents a boron derivative, and R5′ represents either a carbonyl derivative R 2 CO, in which R2 is defined according to claim 1 , or an alkyl carboxylate, in order to obtain a compound of formula (IV):

subsequently reacting the compound of formula (IV) with an organometallic derivative in order to obtain the compound of formula (I).

15. A process for the synthesis of the compound of formula (I), comprising reacting a compound of formula (VI):

wherein R2, R3 and X are defined according to claim 1 and R7 represents R4 as defined in claim 1 or a protective group (PG) for the hydroxyl functional group, with a bromoketone of formula (VII):

wherein R1 is defined according to claim 1 .

16. A process for the synthesis of the compound of formula (I) according to claim 1 , comprising reacting a compound of formula (VI):

wherein R2, R3 and X are defined according to claim 1 and R7 represents R4 as defined in claim 1 or a protective group (PG) for the hydroxyl functional group, with a bromoketone of formula (VII):

wherein R1 is defined according to claim 1 , in order to obtain a compound of formula (VIII):

wherein R7 represents a protective group for the hydroxyl functional group; and

subsequently deprotecting the compound of formula (VIII) in order to obtain the compound of formula (I).

17. A process for the synthesis of the compound of formula (I) according to claim 1 , comprising reacting a compound of formula (XI):

wherein X, R2 and R3 are defined according to claim 1 and R7 represents the R4 group as defined in claim 1 , with a derivative of formula (XII):

R1-Z  (XII),

wherein R1 is defined according to claim 1 and Z represents a boron or tin derivative, in order to obtain the compound of formula (I).

18. A process for the synthesis of the compound of formula (I) according to claim 1 , comprising reacting a compound of formula (XI):

wherein X, R2 and R3 are defined according to claim 1 and R7 represents a protective group for the hydroxyl functional group, with a derivative of formula (XII):

R1-Z  (XII),

wherein R1 is defined according to claim 1 and Z represents a boron or tin derivative, in order to obtain the compounds of formula (VIII):

wherein R1, R2, R3 and X are defined according to claim 1 and R4 represents a hydrogen atom; and

subsequently deprotecting the compound of formula (VIII).

19. A compound selected from the group consisting of: